Apellis Pharmaceuticals Inc (APLS)
41.30
-0.70
(-1.67%)
USD |
NASDAQ |
May 17, 16:00
41.30
0.00 (0.00%)
After-Hours: 20:00
Apellis Pharmaceuticals Free Cash Flow: -550.90M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | -550.90M |
December 31, 2023 | -595.51M |
September 30, 2023 | -639.13M |
June 30, 2023 | -624.61M |
March 31, 2023 | -581.50M |
December 31, 2022 | -515.27M |
September 30, 2022 | -486.19M |
June 30, 2022 | -500.56M |
March 31, 2022 | -522.08M |
December 31, 2021 | -564.23M |
September 30, 2021 | -310.44M |
June 30, 2021 | -245.03M |
March 31, 2021 | -210.92M |
Date | Value |
---|---|
December 31, 2020 | -165.91M |
September 30, 2020 | -389.40M |
June 30, 2020 | -339.91M |
March 31, 2020 | -285.18M |
December 31, 2019 | -212.83M |
September 30, 2019 | -173.54M |
June 30, 2019 | -153.08M |
March 31, 2019 | -143.87M |
December 31, 2018 | -131.24M |
September 30, 2018 | -102.30M |
June 30, 2018 | -80.30M |
March 31, 2018 | -61.10M |
December 31, 2017 | -46.60M |
Free Cash Flow Range, Past 5 Years
-639.13M
Minimum
Sep 2023
-153.08M
Maximum
Jun 2019
-403.31M
Average
-437.80M
Median
Free Cash Flow Benchmarks
Inspire Medical Systems Inc | 3.285M |
Sarepta Therapeutics Inc | -653.88M |
Blueprint Medicines Corp | -429.98M |
Alnylam Pharmaceuticals Inc | 127.82M |
Cytokinetics Inc | -421.55M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -132.98M |
Cash from Investing (Quarterly) | -0.293M |
Cash from Financing (Quarterly) | 108.21M |
Free Cash Flow Per Share (Quarterly) | -1.084 |
Free Cash Flow to Equity (Quarterly) | -133.35M |
Free Cash Flow to Firm (Quarterly) | -129.60M |
Free Cash Flow Yield | -11.03% |